BAY U9773 is a cysteinyl leukotriene receptor antagonist that acts as a valuable pharmacological tool in biochemical research. Specifically, this compound serves as a non-selective blocker of both CysLT1… Read more
BAY U9773 is a cysteinyl leukotriene receptor antagonist that acts as a valuable pharmacological tool in biochemical research. Specifically, this compound serves as a non-selective blocker of both CysLT1 and CysLT2 receptors, enabling laboratories to investigate the signaling pathways of leukotrienes and their involvement in inflammatory processes such as asthma and airway hypersensitivity. In analytical environments, this category includes high-quality reference standards and stable isotope labelled compounds required for precise impurity profiling and method validation. Researchers utilize these materials to ensure the accuracy of quantitative analysis and the consistency of quality control protocols during the assessment of related leukotriene antagonists. By providing reliable benchmarks, these compounds support the rigorous characterization and regulatory testing necessary for the development and study of novel therapeutic agents targeting the cysteinyl leukotriene system.